The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021

OBJECTIVE: To examine the continuation of antibody prevalence status after 12 months and background factors in antibody-positive subjects following asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: We initially determined the SARS-CoV-2 anti-nucleocap...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuba, Ikuro, Takuma, Tetsuo, Hatori, Nobuo, Takai, Masahiko, Watanabe, Yoshiyuki, Takada, Nobukazu, Kishi, Satoru, Matsuzawa, Yoko, Nishikawa, Tetsuo, Kunishima, Tomoyuki, Degawa, Hisakazu, Nishikawa, Masanori, Ono, Yoshiaki, Miyakawa, Masaaki, Hatori, Yutaka, Kanamori, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646357/
https://www.ncbi.nlm.nih.gov/pubmed/35945024
http://dx.doi.org/10.2169/internalmedicine.9628-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646357/
https://www.ncbi.nlm.nih.gov/pubmed/35945024
http://dx.doi.org/10.2169/internalmedicine.9628-22

Ejemplares similares